| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.5 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |